Evidence for and Against Subclinical Disease Activity and Progressive Disease in MOG Antibody Disease and Neuromyelitis Optica Spectrum Disorder.
Autor: | Molazadeh, Negar, Filippatou, Angeliki G., Vasileiou, Eleni S., Levy, Michael, Sotirchos, Elias S. |
---|---|
Zdroj: | Neurology; 12/5/2022 Suppl 2, Vol. 99, pS74-S74, 1p |
Databáze: | Complementary Index |
Externí odkaz: |